Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Rating of “Hold” by Brokerages
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) has been given a consensus rating of “Hold” by the nine research firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and three have issued a buy recommendation on the company. The […]
